Spotlight On... Pharma leaders declare war on antibiotic resistance at Davos; Parnell strikes $15M share-purchase pact; Sanofi launches rabies-info site; Virbac charts strong 2015 growth; and more...

More than 80 pharma companies, including animal health leaders Merck ($MRK) and Sanofi ($SNY), signed a declaration on combating antimicrobial resistance at the World Economic Forum in Davos on Jan. 21. The declaration, which was also signed by 9 industry associations, supports several initiatives aimed at improving how antibiotics are prescribed in both animal and human health, such as promoting more judicious antibiotics use in livestock. It also appeals to governments, insurers and healthcare providers to remove any financial incentives awarded to professionals--including veterinarians--for prescribing antibiotics in high volumes. Release (PDF)

> Parnell Pharmaceuticals ($PARN) entered into a share-purchase agreement that allows it to sell up to $15,000,000 of shares to Chicago-based Lincoln Park Capital Fund over a 36-month period. Release

> At the North American Veterinary Community (NAVC) conference, Sanofi's ($SNY) Merial launched a new website, www.RabiesAware.org, which provides information on state and local vaccination laws. Release

> Virbac announced that its 2015 sales grew 4% at constant exchange rates to €852.2 million ($921.9 million), driven largely by new products for companion animals launched in Europe. Release

> The FDA has issued draft guidance for makers of animal drugs that provides recommendations on the presentation and statistical analysis of safety data. Release

> Vetoquinol Group announced that its 2015 sales grew 4% at constant exchange rates to €342.6 million ($370.7 million), as new products launched late in the year helped offset a general reduction in demand for antibiotics across the animal health sector. Release

> The FDA released its fourth progress report on the judicious use of antimicrobials in food-producing animals. Release

> The Morris Animal Foundation approved 16 grants totaling $1 million for projects focused on improving equine health. Release

> Abbott's Compounding Pharmacy recalled all lots of its products, including those distributed to veterinarians, due to sterility concerns. Release

> Carnivore Meat Company recalled one lot of its Vital Essentials Frozen Chicken Patties Entrée for Dogs due to Salmonella contamination. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…